- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Astrana Health Inc(ASTH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ASTH
11/13/2026: ASTH (1-star) is currently NOT-A-BUY. Pass it for now.
Astrana Health Inc is a technology-powered, risk-bearing healthcare management company that delivers coordinated, value-based medical care through an integrated physician network. The company's primary strengths lie in its scalable, payer-agnostic operating model and robust multi-year revenue growth. Its core investment opportunity centers on capitalizing on the secular shift toward value-based care and successfully integrating major acquisitions like Prospect Health. However, investors must weigh risks such as thin operating margins, increasing balance sheet leverage, and regulatory exposure to government-sponsored healthcare programs. The stock is best suited for growth-oriented investors willing to monitor integration execution, debt levels, and ongoing margin improvements.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Rapid top-line revenue expansion and aggressive scaling in the high-growth value-based care sector match growth criteria. |
| Momentum investor | Strong fit while signal remains positive | Strong institutional attention and consistent multi-year revenue growth attract momentum participants when price trends are favorable. |
| Value investor | Mixed fit | While forward valuation multiples appear reasonable relative to growth, rising goodwill and leverage require careful fundamental scrutiny. |
| Dividend investor | Weak fit | Astrana does not pay a cash dividend, focusing entirely on reinvestment and business expansion. |
| Low-risk investor | Weak fit | Healthcare regulatory shifts, integration execution risks, and share price volatility make it less suitable for risk-averse portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock experiences fluctuations driven by market sentiment on healthcare policy and quarterly earnings execution. |
| Valuation risk | Medium | Multiples depend heavily on sustained high growth and successful integration of large-scale acquisitions. |
| Competition risk (managed care and value-based enablers) | Medium / high | Intense competition from large health insurers and specialized care aggregators could pressure margins and network growth. |
| Business quality | Medium / high | The franchise benefits from strong physician alignment and scalable tech infrastructure, though margins remain thin. |
| Dividend income | Low / none | Zero dividend yield means investors rely completely on capital appreciation. |
| Execution risk | Medium / high | Successfully integrating large acquisitions like Prospect Health is critical to realizing projected synergies. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.58B USD | Price to earnings Ratio 29.44 | 1Y Target Price 51.89 |
Price to earnings Ratio 29.44 | 1Y Target Price 51.89 | ||
Volume (30-day avg) 360.2K shares | Beta 1.24 | 52 Weeks Range 18.08 - 51.60 | Updated Date 11/15/2026 |
52 Weeks Range 18.08 - 51.60 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.08 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -28.13% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Care Partners Segment | Capitated fees and risk-sharing arrangements from health plans for managing the medical care of assigned patient populations. | This is the primary revenue engine, generating income by efficiently managing healthcare costs under risk contracts. |
| Care Delivery Segment | Fee-for-service and value-based clinical revenues from company-operated primary care, multi-specialty, and immediate care clinics. | Provides direct clinical services revenue through physical medical facilities and affiliated physician practices. |
| Care Enablement Segment | Administrative, management, and technology services fees provided to independent physician groups and health plans. | Monetizes the company's administrative and technological infrastructure by assisting external providers. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 0.44 | Actual 0.26 |
Profitability
Profit Margin 1.36% | Operating Margin (TTM) 2.62% |
Management Effectiveness
Return on Assets (TTM) 2.79% | Return on Equity (TTM) 9.85% |
Valuation
Trailing PE 29.44 | Forward PE 8.3 | Enterprise Value 2.16B | Price to Sales(TTM) 0.4 |
Enterprise Value 2.16B | Price to Sales(TTM) 0.4 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA 10.07 | Shares Outstanding 49.67M | Shares Floating 45.71M |
Shares Outstanding 49.67M | Shares Floating 45.71M | ||
Percent Insiders 23.13 | Percent Institutions 69.89 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

